Investors
Key press releases
Key corporate presentation
Cellectis is listed on the Nasdaq Global Market (ticker: CLLS) and on the Euronext Growth Paris (ticker: ALCLS).
Cellectis ADS (Nasdaq)
Ticker: CLLS
$2.1900
+0.0300 (1.3889%)
- Prev. close
- 2.1600
- Volume
- 41,503
- High
- 2.2500
- Capitalization
- 157.885M
Cellectis (Euronext Growth Paris)
Ticker: ALCLS
€1.9400
+0.0260 (1.3584%)
- Prev. close
- 1.9140
- Volume
- 22,675
- High
- 1.9680
- Capitalization
- 139.862M
Covering research analysts
Barclays - Gena Wang
Bryan Garnier - Oscar Haffen-Lamm
Citi - Yigal Nochomovitz
Goldman Sachs - Salveen Richter
Jefferies - Kelly Shi
JMP Securities - Silvan Tuerkcan
Jones Trading - Soumit Roy
Kempen - Sebastiaan van der Schoot
Oddo BHF - Martial Descoutures
RW Baird - Jack Allen
Wells Fargo – Yanan Zhu
Cellectis contact information
Arthur Stril, Interim Chief Financial Officer
Citibank ADR contact information
Intermediaries & Investors
US: +1 212 723 5435
UK: +44 207 500 2030
Société Générale Securities Services - Ordinary Shares contact information
Call center in English and French
Monday to Friday from 8:30am to 6pm CEST
+33 (0)2 51 85 67 89